HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024

About this update from Harmony Biosciences Holdings, Inc.

[{"type":"text","content":"PLYMOUTH MEETING, Pa., April 16, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report first quarter 2024 financial results on Tuesday, April 30, 2024, before the open of the U.S. financial markets. Harmony will host a conference call and live webcast on April 30, 2024, at 8:30 a.m. ET to discuss the results.\n\n \n \n \n \n \n \n\n \nTo participate in the call, please dial (800) 579-2543 (domestic) or +1 (785) 424-1789 (international), and reference passcode HRMYQ124. It is recommended that you dial in at least 10 minutes prior to the call.\nThe live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.\nAbout Harmony Biosciences At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.\nHarmony Biosciences Investor Contact:Luis Sanay, [email protected]\nHarmony Biosciences Media Contact: Cate McCanless202-641-6086 [email protected]\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-first-quarter-2024-financial-results-on-april-30-2024-302117222.html\nSOURCE Harmony Biosciences","length":3800,"tagName":"div"}]

More updates from Harmony Biosciences Holdings, Inc.